NinoMed
Generated 5/9/2026
Executive Summary
NinoMed is a medical device and business analytics company founded in 2015 by a surgeon, headquartered in San Diego, CA, with operations in Syracuse, NY. The company specializes in patient positioning systems for robotic and laparoscopic surgeries, aiming to enhance surgical safety and efficiency. Additionally, it offers a revenue cycle management analytics platform to optimize healthcare system financial performance. With a focus on innovation and value-based care, NinoMed targets the growing demand for minimally invasive surgical accessories and data-driven healthcare solutions. The company is privately held and has not publicly disclosed funding or valuation, but its dual product lines address distinct market needs: surgical positioning and healthcare analytics. As a relatively small player, NinoMed faces competition from larger medical device firms and analytics providers, but its niche focus and surgeon-founded leadership may provide credibility and market fit. The company's stage and commercial traction are unclear from available data, suggesting early to mid-stage development.
Upcoming Catalysts (preview)
- Q3 2026FDA Clearance for Next-Generation Positioning System60% success
- Q4 2026Major Hospital System Contract for Analytics Platform45% success
- Q1 2027Strategic Partnership with Robotic Surgery Platform Provider40% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)